US Stem Cell Inc (USRM)

[Rhinegold]

Yes, Dr. Murphy has experience in this regard(and connections)



Dr. William P. Murphy, Jr., M.D.

Chairman of the Board

Dr. William P. Murphy, Jr., currently serves the Chairman of the Board of U.S. Stem Cell, having joined the as a member of the Board of Directors in June 2003. A highly successful entrepreneur and inventor, the owner of 17 patents, a distinguished speaker and published author, Dr. Murphy founded Small Parts, Inc., a supplier of high quality mechanical components for design engineers in 1964 and served as its Chairman until his retirement in April 2005. Small Parts, Inc. was later acquired by Amazon.com, Inc. in March 2005. From October 1999 until October 2004, Dr. Murphy served as the Chairman and Chief Executive Officer of Hyperion, Inc., a medical diagnosis company which filed for involuntary bankruptcy in December 2003.

Dr. Murphy is the founder of Cordis Corporation (now Cordis Johnson & Johnson) which he led as President, Chairman and Chief Executive Officer at various times during his 28 years at Cordis until his retirement in October 1985. Cordis Johnson & Johnson is a leading firm in cardiovascular instrumentation. Dr. Murphy received an M.D. in 1947 from the University of Illinois and a B.S in pre-medicine from Harvard College in 1946. He also studied physiologic instrumentation at Massachusetts Institute of Technology. Dr. Murphy is the recipient of a number of honors, including the prestigious Lemelson-MIT Lifetime Achievement Award, the MIT Corporate Leadership Award, the Distinguished Service Award from North American Society of Pacing and Electrophysiology and the Jay Malina Award from the Beacon Council, Miami-Dade County’s economic development arm.




http://www.nytimes.com/1995/11/07/business/cordis-to-be-acquired-by-johnson-johnson.html

The Cordis Corporation agreed yesterday to be acquired by Johnson & Johnson after its buyout offer was raised to $1.8 billion in stock from $1.6 billion.


Without a full line of cardiovascular devices, Johnson & Johnson would have been at a disadvantage when competitors introduced their own stents in the United States in the next few years.



Also remember Dr. Murphy, recent Form 4 Filings and buying.

I smell Buyout!!